Collectionner le produit
Détails du produit
Synonyms
TNFRSF17, CD269, BCM, BCMA
Source
Alexa Fluor 555-Labeled Human BCMA, His Tag (BCA-HA2H7) is produced via conjugation of AF555 to Human BCMA, His Tag with a new generation site-specific technology under Star Staining labeling platform. Human BCMA, His Tag is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 54 (Accession # Q02223-1).
Predicted N-terminus: Met 1
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
Conjugate
AF555
Excitation Wavelength: 561 nm
Emission Wavelength: 572 nm
Purity
>90% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Evaluation of CAR expression
FACS Analysis of Anti-BCMA CAR Expression
5e5 of anti-BCMA CAR-293 cells were stained with 100 μL of 3 μg/mL of Alexa Fluor 555-Labeled Human BCMA, His Tag (Cat. No. BCA- HA2H7) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). Alexa 555 signal was used to evaluate the binding activity (QC tested).
ProtocolFACS Analysis of Non-specific binding to PBMCs
5e5 of PBMCs were stained with Alexa Fluor 555-Labeled Human BCMA, His Tag (Cat. No. BCA-HA2H7) and anti-CD3 antibody, washed and then analyzed with FACS. FITC signal was used to evaluate the expression of CD3+T cells in PBMCs, and Alexa 555 signal was used to evaluate the non-specific binding activity to PBMCs (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire
Introduction de fond
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
B-cell maturation protein
- Catégorie：
- Nombre de médicaments répertoriés：
8 Détails
- Nombre de médicaments cliniques：
145 Détails
- Étape de développement la plus élevée：
Approved
Contact Us
Drug Candidate Licensing
